Tatsuya Fukuda1, Satoru Tsuiki2, Mina Kobayashi3, Hideaki Nakayama4, Yuichi Inoue3. 1. Neuropsychiatric Research Institute, Tokyo, Japan. 2. Neuropsychiatric Research Institute, Tokyo, Japan; Department of Somnology, Tokyo Medical University, Tokyo, Japan; Yoyogi Sleep Disorder Center, Tokyo, Japan. Electronic address: tsuiki@somnology.com. 3. Neuropsychiatric Research Institute, Tokyo, Japan; Department of Somnology, Tokyo Medical University, Tokyo, Japan; Yoyogi Sleep Disorder Center, Tokyo, Japan. 4. Department of Respiratory Medicine, Tokyo Medical University, Tokyo, Japan.
Abstract
BACKGROUND: In oral appliance therapy for obstructive sleep apnea (OSA), treatment success is arbitrarily defined. We investigated if the selection of response criteria affected the success rate of oral appliance treatment. METHODS: The effects of an oral appliance on apnea-hypopnea index (AHI) and nadir percutaneous oxygen saturation (SpO2) were investigated in 224 OSA patients. Treatment success was defined as a reduction in AHI to <5 events per hour with a >50% reduction in baseline AHI (criterion 1), a follow-up AHI of <10 events per hour with a >50% reduction in baseline AHI (criterion 2), a >50% reduction in baseline AHI alone (criterion 3), or a >50% reduction in baseline AHI with the nadir SpO2 above 90% (criterion 4). RESULTS: The baseline AHI was reduced with an oral appliance in place compared with the follow-up value (23 ± 11-8.5 ± 8.7 events/h; P<.05) in all of the participants. In every OSA subgroup, the success rate under criterion 3 (75% [mild], 71% [moderate], and 70% [severe]) was greater than that under criterion 1 (53%, 40%, and 24%, respectively). However, responders under criterion 3 in the severe OSA subgroup were still hypoxemic with a nadir SpO2 of 87 ± 8% even after treatment. This situation was improved by the use of criterion 4, in which a satisfactory improvement in AHI (from 38 ± 11 to 1 ± 1 events/h; P<.01) was associated with a sufficient increase in the nadir SpO2 (93 ± 2%). CONCLUSIONS: We conclude that the selection of response criteria influences the success rate of oral appliance treatment. To avoid adverse health outcomes, an adjunct definition of treatment success using SpO2 may be effective for patients who have more severe OSA.
BACKGROUND: In oral appliance therapy for obstructive sleep apnea (OSA), treatment success is arbitrarily defined. We investigated if the selection of response criteria affected the success rate of oral appliance treatment. METHODS: The effects of an oral appliance on apnea-hypopnea index (AHI) and nadir percutaneous oxygen saturation (SpO2) were investigated in 224 OSA patients. Treatment success was defined as a reduction in AHI to <5 events per hour with a >50% reduction in baseline AHI (criterion 1), a follow-up AHI of <10 events per hour with a >50% reduction in baseline AHI (criterion 2), a >50% reduction in baseline AHI alone (criterion 3), or a >50% reduction in baseline AHI with the nadir SpO2 above 90% (criterion 4). RESULTS: The baseline AHI was reduced with an oral appliance in place compared with the follow-up value (23 ± 11-8.5 ± 8.7 events/h; P<.05) in all of the participants. In every OSA subgroup, the success rate under criterion 3 (75% [mild], 71% [moderate], and 70% [severe]) was greater than that under criterion 1 (53%, 40%, and 24%, respectively). However, responders under criterion 3 in the severe OSA subgroup were still hypoxemic with a nadir SpO2 of 87 ± 8% even after treatment. This situation was improved by the use of criterion 4, in which a satisfactory improvement in AHI (from 38 ± 11 to 1 ± 1 events/h; P<.01) was associated with a sufficient increase in the nadir SpO2 (93 ± 2%). CONCLUSIONS: We conclude that the selection of response criteria influences the success rate of oral appliance treatment. To avoid adverse health outcomes, an adjunct definition of treatment success using SpO2 may be effective for patients who have more severe OSA.
Authors: Kate Sutherland; Hisashi Takaya; Jin Qian; Peter Petocz; Andrew T Ng; Peter A Cistulli Journal: J Clin Sleep Med Date: 2015-08-15 Impact factor: 4.062
Authors: Sara Op de Beeck; Marijke Dieltjens; Annelies E Verbruggen; Anneclaire V Vroegop; Kristien Wouters; Evert Hamans; Marc Willemen; Johan Verbraecken; Wilfried A De Backer; Paul H Van de Heyning; Marc J Braem; Olivier M Vanderveken Journal: J Clin Sleep Med Date: 2019-08-15 Impact factor: 4.062
Authors: Erin V Mosca; Sabina Bruehlmann; Shaelynn M Zouboules; Alexandra E Chiew; Curtis Westersund; Dillon A Hambrook; Seyed A Zareian Jahromi; Joshua Grosse; Zbigniew L Topor; Shouresh Charkhandeh; John E Remmers Journal: J Clin Sleep Med Date: 2022-03-01 Impact factor: 4.062
Authors: Eli Van de Perck; Sara Op de Beeck; Marijke Dieltjens; Anneclaire V Vroegop; Annelies E Verbruggen; Marc Willemen; Johan Verbraecken; Paul H Van de Heyning; Marc J Braem; Olivier M Vanderveken Journal: J Clin Sleep Med Date: 2020-07-15 Impact factor: 4.062